JSR Corporation (JSCPY)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
JSR Corporation (JSCPY) with AI Score 44/100 (Weak). JSR Corporation operates in the elastomers, plastics, digital solutions, and life sciences sectors, serving diverse industries globally. Market cap: 0, Sector: Basic materials.
Last analyzed: Mar 16, 2026JSR Corporation (JSCPY) Materials & Commodity Exposure
JSR Corporation, a Japanese multinational, specializes in elastomers, plastics, digital solutions, and life sciences. With a global presence, JSR serves industries ranging from automotive and electronics to biopharmaceuticals, offering synthetic rubbers, photoresists, and chromatography resins. The company's focus on innovation positions it within the specialty chemicals market.
Investment Thesis
JSR Corporation's diversified business model, spanning elastomers, plastics, digital solutions, and life sciences, offers resilience across economic cycles. The company's focus on high-growth sectors like semiconductors and biopharmaceuticals presents significant growth opportunities. However, JSR's negative profit margin of -1.4% and a high P/E ratio of -162.30 indicate potential challenges. Investors should monitor the company's ability to improve profitability and capitalize on its strategic investments in key growth areas. Upcoming advancements in semiconductor materials and bioprocessing technologies could serve as catalysts.
Based on FMP financials and quantitative analysis
Key Highlights
- JSR Corporation operates in four key segments: Elastomers, Plastics, Digital Solutions, and Life Sciences, providing diversification across industries.
- The company's Gross Margin stands at 33.3%, reflecting its ability to maintain profitability in its core businesses.
- JSR Corporation's Digital Solutions business caters to the semiconductor and display industries, positioning it in high-growth markets.
- The Life Sciences segment provides diagnostic reagents and biopharmaceutical development services, offering exposure to the healthcare sector.
- JSR Corporation's beta of 0.65 indicates lower volatility compared to the broader market.
Competitors & Peers
Strengths
- Diversified business segments across multiple industries.
- Strong technological capabilities in materials science.
- Global presence and established customer relationships.
- Focus on high-growth sectors like semiconductors and biopharmaceuticals.
Weaknesses
- Negative profit margin and high P/E ratio.
- Dependence on cyclical industries like automotive and electronics.
- Exposure to currency fluctuations.
- Limited brand recognition compared to larger competitors.
Catalysts
- Ongoing: Increasing demand for semiconductor materials driven by the growth of AI and IoT.
- Ongoing: Expansion of the biopharmaceutical market and demand for advanced drug manufacturing technologies.
- Upcoming: Potential partnerships with leading technology companies to develop innovative materials.
- Ongoing: Government initiatives and investments in the semiconductor and biopharmaceutical industries.
Risks
- Potential: Economic downturns and fluctuations in demand for specialty chemicals.
- Ongoing: Intense competition from established chemical companies.
- Potential: Disruptions in supply chains and raw material costs.
- Ongoing: Currency fluctuations affecting the value of ADRs.
- Potential: Changes in regulations and environmental standards.
Growth Opportunities
- Growth opportunity 1: Expansion in the semiconductor materials market presents a significant opportunity for JSR's Digital Solutions business. The global semiconductor materials market is projected to reach $78.7 billion by 2026, driven by increasing demand for advanced chips in electronics and automotive applications. JSR's photoresists and CMP materials are critical components in semiconductor manufacturing, positioning the company to capitalize on this growth. Timeline: Ongoing.
- Growth opportunity 2: The biopharmaceutical market offers substantial growth potential for JSR's Life Sciences business. The global biopharmaceutical market is expected to reach $388.3 billion by 2024, driven by increasing demand for biologics and personalized medicine. JSR's chromatography resins and bioprocess materials are used in the purification and manufacturing of biopharmaceuticals, positioning the company to benefit from this trend. Timeline: Ongoing.
- Growth opportunity 3: JSR can leverage its expertise in elastomers to develop sustainable and high-performance materials for the automotive industry. The increasing demand for electric vehicles and fuel-efficient vehicles is driving the need for lightweight and durable materials. JSR's synthetic rubbers and thermoplastic elastomers can be used in tires, seals, and other automotive components, offering a growth opportunity in the automotive sector. Timeline: Ongoing.
- Growth opportunity 4: JSR's expansion into new geographic markets, particularly in Asia-Pacific, can drive revenue growth. The Asia-Pacific region is experiencing rapid economic growth and increasing demand for specialty chemicals. By establishing a stronger presence in this region, JSR can tap into new customer segments and increase its market share. Timeline: Ongoing.
- Growth opportunity 5: JSR can invest in research and development to develop innovative materials and solutions for emerging applications. This includes developing advanced materials for energy storage, displays, and medical devices. By staying at the forefront of technological advancements, JSR can maintain its competitive edge and capture new growth opportunities. Timeline: Ongoing.
Opportunities
- Expansion in the semiconductor materials market.
- Growth in the biopharmaceutical market.
- Development of sustainable materials for the automotive industry.
- Expansion into new geographic markets in Asia-Pacific.
Threats
- Intense competition from established chemical companies.
- Economic downturns and fluctuations in demand.
- Disruptions in supply chains and raw material costs.
- Changes in regulations and environmental standards.
Competitive Advantages
- Specialized knowledge and expertise in specialty chemicals.
- Strong relationships with key customers in the semiconductor, display, and biopharmaceutical industries.
- Proprietary technologies and intellectual property in materials science.
- Diversified product portfolio across multiple industries.
About JSCPY
Founded in 1948 and headquartered in Tokyo, Japan, JSR Corporation has evolved into a diversified chemical company with a global footprint. Initially focused on synthetic rubber production, JSR expanded its portfolio to include plastics, digital solutions, and life sciences. The Elastomers Business segment provides synthetic rubbers for tires and automotive parts. The Digital Solutions Business offers photoresists and materials for semiconductors and displays. The Life Sciences Business focuses on diagnostic reagents, chromatography resins, and biopharmaceutical development services. The Plastics Business provides synthetic resins for various applications. JSR's strategic diversification enables it to serve a wide range of industries, including automotive, electronics, and healthcare. The company's commitment to research and development drives innovation and product development.
What They Do
- Develops and manufactures synthetic rubbers for the automotive and industrial sectors.
- Provides photoresists and other materials for semiconductor manufacturing.
- Offers materials for LCD and OLED displays.
- Produces chromatography resins for biopharmaceutical purification.
- Manufactures synthetic resins for automotive parts and household appliances.
- Provides diagnostic and research reagents for the life sciences industry.
- Offers drug discovery and development services.
Business Model
- Manufacturing and sale of specialty chemical products.
- Providing solutions and services to the semiconductor and display industries.
- Offering products and services to the biopharmaceutical industry.
- Supplying materials to the automotive and electronics industries.
Industry Context
JSR Corporation operates within the specialty chemicals industry, which is characterized by innovation, customization, and high value-added products. The industry is influenced by trends such as increasing demand for advanced materials in electronics, automotive, and healthcare. Competitors include companies like GAEC, GTBT, MSLM, NWGN and WWST. JSR's focus on digital solutions and life sciences aligns with the growing demand for specialized materials and services in these sectors, positioning it for potential growth.
Key Customers
- Tire manufacturers and automotive parts suppliers.
- Semiconductor manufacturers and display panel producers.
- Biopharmaceutical companies and research institutions.
- Electronics manufacturers and household appliance producers.
Financials
Chart & Info
JSR Corporation (JSCPY) stock price: Price data unavailable
Latest News
No recent news available for JSCPY.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for JSCPY.
Price Targets
Wall Street price target analysis for JSCPY.
MoonshotScore
What does this score mean?
The MoonshotScore rates JSCPY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Eric R. Johnson
CEO
Eric R. Johnson is the CEO of JSR Corporation, overseeing the company's global operations and strategic direction. His background includes extensive experience in the chemical and materials industries, with a focus on innovation and business development. Prior to joining JSR, Johnson held leadership positions at various multinational corporations, where he led teams in research, manufacturing, and sales. He holds degrees in chemical engineering and business administration.
Track Record: Under Eric R. Johnson's leadership, JSR Corporation has focused on expanding its presence in high-growth sectors like semiconductors and biopharmaceuticals. He has overseen strategic investments in research and development to drive innovation and product development. Johnson has also emphasized sustainability and corporate social responsibility, aligning JSR's operations with environmental and social goals. His tenure has focused on global expansion and technological advancement.
JSR Corporation ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. JSCPY functions as a Level 1 ADR, meaning it trades over-the-counter (OTC) without requiring the same level of regulatory compliance as listed stocks. This allows U.S. investors to invest in JSR Corporation more easily.
- Home Market Ticker: Tokyo Stock Exchange, Japan
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: JSCP
JSCPY OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that JSR Corporation (JSCPY) may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors, increasing the risk of investing. Trading on this tier does not guarantee the legitimacy or financial health of the company.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Potential for fraud or manipulation.
- Low trading volume and liquidity.
- Higher price volatility.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Check for any regulatory actions or legal issues.
- Established history of operations.
- Presence of a functional website and contact information.
- Availability of some financial information, even if limited.
- Involvement of reputable professionals or advisors.
- Positive news coverage or industry recognition.
JSR Corporation Stock: Key Questions Answered
What does JSR Corporation do?
JSR Corporation is a diversified chemical company that operates in the elastomers, plastics, digital solutions, and life sciences sectors. The company's Elastomers Business segment provides synthetic rubbers for tires and automotive parts. The Digital Solutions Business offers photoresists and materials for semiconductors and displays. The Life Sciences Business focuses on diagnostic reagents, chromatography resins, and biopharmaceutical development services. The Plastics Business provides synthetic resins for various applications. JSR serves a wide range of industries, including automotive, electronics, and healthcare.
What do analysts say about JSCPY stock?
As of March 16, 2026, there is no readily available analyst consensus on JSCPY stock due to its OTC listing and limited coverage. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and risk factors. Key valuation metrics include the P/E ratio, profit margin, and gross margin. Investors should also monitor the company's ability to improve profitability and capitalize on its strategic investments in key growth areas. The company's diversification into high-growth sectors like semiconductors and biopharmaceuticals is a key consideration.
What are the main risks for JSCPY?
Investing in JSR Corporation (JSCPY) involves several risks. The company's negative profit margin and high P/E ratio indicate potential financial challenges. JSCPY is exposed to fluctuations in the demand for specialty chemicals, particularly in cyclical industries like automotive and electronics. Currency fluctuations can also affect the value of the ADR. As an OTC stock, JSCPY carries additional risks related to limited disclosure, liquidity, and regulatory oversight. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for JSCPY?
JSR Corporation (JSCPY) currently holds an AI score of 44/100, indicating low score. Key strength: Diversified business segments across multiple industries.. Primary risk to monitor: Potential: Economic downturns and fluctuations in demand for specialty chemicals.. This is not financial advice.
How frequently does JSCPY data refresh on this page?
JSCPY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven JSCPY's recent stock price performance?
Recent price movement in JSR Corporation (JSCPY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified business segments across multiple industries.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider JSCPY overvalued or undervalued right now?
Determining whether JSR Corporation (JSCPY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying JSCPY?
Before investing in JSR Corporation (JSCPY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the latest available information.
- Analyst consensus may not be available due to limited coverage.
- OTC market investments carry additional risks.